(Q30615539)

25 June 2017

1 reference

title

Neuroimaging in bipolar disorder: what have we learned? (English)

1 reference

25 June 2017

0 references

1 reference

Stoll AL

1

1 reference

25 June 2017

Renshaw PF

series ordinal

2

1 reference

25 June 2017

Yurgelun-Todd DA

series ordinal

3

1 reference

25 June 2017

Cohen BM

series ordinal

4

1 reference

25 June 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

25 June 2017

Biological Psychiatry

1 reference

25 June 2017

48

1 reference

25 June 2017

505-517

1 reference

25 June 2017

6

1 reference

Limbic dysfunction in schizophrenia and mania. A study using 18F-labelled fluorodeoxyglucose and positron emission tomography.

25 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Fluorine-18 radiolabelling, biodistribution studies and preliminary PET evaluation of a new memantine derivative for imaging the NMDA receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Reduction of prefrontal cortex glucose metabolism common to three types of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Functional mapping of the human visual cortex by magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Neural and developmental actions of lithium: a unifying hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

In vivo quantitation of cerebral metabolite concentrations using natural abundance 13C MRS at 1.5 T.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

MRI abnormalities in adolescent bipolar affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Quantitation of dexfenfluramine/d-norfenfluramine concentration in primate brain using 19F NMR spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Differences between antipsychotic drugs in persistence of brain levels and behavioral effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Regional brain function, emotion and disorders of emotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Abnormal frontal lobe phosphorous metabolism in bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

MRI analysis of the cerebellum in bipolar disorder: a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Neuroimaging and neurobiological models of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

In vivo imaging of serotonin transporters with [99mTc]TRODAT-1 in nonhuman primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

PET imaging of serotonin 1A receptor binding in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Subgenual prefrontal cortex abnormalities in mood disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Gross Pathology of the Cerebellum in Patients Diagnosed and Treated as Functional Psychiatric Disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Proton spectroscopy without water suppression: the oversampled J-resolved experiment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Neuroanatomical studies of major affective disorders. A review and suggestions for further research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Magnetic resonance spectroscopy in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

In vivo detection of GABA in human brain using a localized double-quantum filter technique.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

A review of functional neuroimaging in mood disorders: positron emission tomography and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Using single photon emission tomography (SPECT) and positron emission tomography (PET) to trace the distribution of muscarinic acetylcholine receptor (MACHR) binding radioligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Effect of tracer metabolism on PET measurement of [11C]pyrilamine binding to histamine H1 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Positive correlation between reduction of handwriting area and D2 dopamine receptor occupancy during treatment with neuroleptic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Applications of dynamic susceptibility contrast magnetic resonance imaging in Neuropsychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Cerebellar vermis dimensions on computerized tomographic scans of schizophrenic and bipolar patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Differences in cerebellar blood volume in schizophrenia and bipolar disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Broadband proton decoupling in human 31P NMR spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Hyperintense lesions on magnetic resonance images in bipolar disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Simultaneous in vivo spectral editing and water suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Effects of myo-inositol ingestion on human brain myo-inositol levels: a proton magnetic resonance spectroscopic imaging study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Proton-decoupled 31P chemical shift imaging of the human brain in normal volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Synthesis of an I-123 analog of A-85380 and preliminary SPECT imaging of nicotinic receptors in baboon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Cerebral ventricular enlargement in young manic males. A controlled CT study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

High spatial resolution and speed in MRSI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Structural changes in the brain of patients with bipolar affective disorder by MRI: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

In Vivo D2 Dopamine Receptor Density in Psychotic and Nonpsychotic Patients With Bipolar Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Clinical neuroimaging in psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Structural brain abnormalities in the major psychoses: a quantitative review of the evidence from computerized imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Susceptibility contrast imaging of cerebral blood volume: human experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Localized 1H NMR spectra of glutamate in the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

3D localized 2D NMR spectroscopy on an MRI scanner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

The cerebellar cognitive affective syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Quantitative diffusion-tensor anisotropy brain MR imaging: normative human data and anatomic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Effects of lithium and amphetamine on inositol metabolism in the human brain as measured by 1H and 31P MRS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Quantification of delta-opioid receptors in human brain with N1'-([11C]methyl) naltrindole and positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

The anatomy of mood disorders--review of structural neuroimaging studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

The functional neuroanatomy of mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Manic-depressive and pure manic states after brain lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

The human brain resonance of choline-containing compounds is similar in patients receiving lithium treatment and controls: an in vivo proton magnetic resonance spectroscopy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first psychiatric hospitalization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Structural brain abnormalities in first-episode mania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

MRI subcortical signal hyperintensities in mania at first hospitalization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Brain elimination half-life of fluvoxamine measured by 19F magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

D1 dopamine receptor binding in mood disorders measured by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Structural brain abnormalities in bipolar affective disorder. Ventricular enlargement and focal signal hyperintensities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Kinetic analysis of [11C]McN5652: a serotonin transporter radioligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

A new multiple quantum filter design procedure for use on strongly coupled spin systems found in vivo: its application to glutamate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

MRI findings in patients with affective disorder: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Performance of 2D 1H spectroscopic imaging of the brain: some practical considerations regarding the measurement procedure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Effects of vigabatrin intake on brain GABA activity as monitored by spectrally edited magnetic resonance spectroscopy and positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Computed tomography in schizophreniform disorder and other acute psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Cerebellar atrophy in schizophrenia and affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Cardiovascular risk factors in affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Deficits in gray matter volume are present in schizophrenia but not bipolar disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

Gender and age influences on human brain mu-opioid receptor binding measured by PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900982-3

10.1016/S0006-3223(00)00982-3

7 January 2021

Identifiers

DOI

1 reference

25 June 2017

1 reference